Cargando…

Mass spectrometric analysis of chondroitin sulfate-linked peptides

Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix components composed of linear glycosaminoglycan (GAG) side chains attached to a core protein. CSPGs play a vital role in neurodevelopment, signal transduction, cellular proliferation and differentiation and tumor metastasis through i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramarajan, Madan Gopal, Saraswat, Mayank, Budhraja, Rohit, Garapati, Kishore, Raymond, Kimiyo, Pandey, Akhilesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526814/
https://www.ncbi.nlm.nih.gov/pubmed/36213313
http://dx.doi.org/10.1007/s42485-022-00092-3
_version_ 1784800960127696896
author Ramarajan, Madan Gopal
Saraswat, Mayank
Budhraja, Rohit
Garapati, Kishore
Raymond, Kimiyo
Pandey, Akhilesh
author_facet Ramarajan, Madan Gopal
Saraswat, Mayank
Budhraja, Rohit
Garapati, Kishore
Raymond, Kimiyo
Pandey, Akhilesh
author_sort Ramarajan, Madan Gopal
collection PubMed
description Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix components composed of linear glycosaminoglycan (GAG) side chains attached to a core protein. CSPGs play a vital role in neurodevelopment, signal transduction, cellular proliferation and differentiation and tumor metastasis through interaction with growth factors and signaling proteins. These pleiotropic functions of proteoglycans are regulated spatiotemporally by the GAG chains attached to the core protein. There are over 70 chondroitin sulfate-linked proteoglycans reported in cells, cerebrospinal fluid and urine. A core glycan linker of 3–6 monosaccharides attached to specific serine residues can be extended by 20–200 disaccharide repeating units making intact CSPGs very large and impractical to analyze. The current paradigm of CSPG analysis involves digesting the GAG chains by chondroitinase enzymes and analyzing either the protein part, the disaccharide repeats, or both by mass spectrometry. This method, however, provides no information about the site of attachment or the composition of linker oligosaccharides and the degree of sulfation and/or phosphorylation. Further, the analysis by mass spectrometry and subsequent identification of novel CSPGs is hampered by technical challenges in their isolation, less optimal ionization and data analysis. Unknown identity of the linker oligosaccharide also makes it more difficult to identify the glycan composition using database searching approaches. Following chondroitinase digestion of long GAG chains linked to tryptic peptides, we identified intact GAG-linked peptides in clinically relevant samples including plasma, urine and dermal fibroblasts. These intact glycopeptides including their core linker glycans were identified by mass spectrometry using optimized stepped higher energy collision dissociation and electron-transfer/higher energy collision dissociation combined with hybrid database search/de novo glycan composition search. We identified 25 CSPGs including three novel CSPGs that have not been described earlier. Our findings demonstrate the utility of combining enrichment strategies and optimized high-resolution mass spectrometry analysis including alternative fragmentation methods for the characterization of CSPGs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42485-022-00092-3.
format Online
Article
Text
id pubmed-9526814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-95268142022-10-03 Mass spectrometric analysis of chondroitin sulfate-linked peptides Ramarajan, Madan Gopal Saraswat, Mayank Budhraja, Rohit Garapati, Kishore Raymond, Kimiyo Pandey, Akhilesh J Proteins Proteom Original Article Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix components composed of linear glycosaminoglycan (GAG) side chains attached to a core protein. CSPGs play a vital role in neurodevelopment, signal transduction, cellular proliferation and differentiation and tumor metastasis through interaction with growth factors and signaling proteins. These pleiotropic functions of proteoglycans are regulated spatiotemporally by the GAG chains attached to the core protein. There are over 70 chondroitin sulfate-linked proteoglycans reported in cells, cerebrospinal fluid and urine. A core glycan linker of 3–6 monosaccharides attached to specific serine residues can be extended by 20–200 disaccharide repeating units making intact CSPGs very large and impractical to analyze. The current paradigm of CSPG analysis involves digesting the GAG chains by chondroitinase enzymes and analyzing either the protein part, the disaccharide repeats, or both by mass spectrometry. This method, however, provides no information about the site of attachment or the composition of linker oligosaccharides and the degree of sulfation and/or phosphorylation. Further, the analysis by mass spectrometry and subsequent identification of novel CSPGs is hampered by technical challenges in their isolation, less optimal ionization and data analysis. Unknown identity of the linker oligosaccharide also makes it more difficult to identify the glycan composition using database searching approaches. Following chondroitinase digestion of long GAG chains linked to tryptic peptides, we identified intact GAG-linked peptides in clinically relevant samples including plasma, urine and dermal fibroblasts. These intact glycopeptides including their core linker glycans were identified by mass spectrometry using optimized stepped higher energy collision dissociation and electron-transfer/higher energy collision dissociation combined with hybrid database search/de novo glycan composition search. We identified 25 CSPGs including three novel CSPGs that have not been described earlier. Our findings demonstrate the utility of combining enrichment strategies and optimized high-resolution mass spectrometry analysis including alternative fragmentation methods for the characterization of CSPGs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42485-022-00092-3. Springer Nature Singapore 2022-10-02 2022 /pmc/articles/PMC9526814/ /pubmed/36213313 http://dx.doi.org/10.1007/s42485-022-00092-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Ramarajan, Madan Gopal
Saraswat, Mayank
Budhraja, Rohit
Garapati, Kishore
Raymond, Kimiyo
Pandey, Akhilesh
Mass spectrometric analysis of chondroitin sulfate-linked peptides
title Mass spectrometric analysis of chondroitin sulfate-linked peptides
title_full Mass spectrometric analysis of chondroitin sulfate-linked peptides
title_fullStr Mass spectrometric analysis of chondroitin sulfate-linked peptides
title_full_unstemmed Mass spectrometric analysis of chondroitin sulfate-linked peptides
title_short Mass spectrometric analysis of chondroitin sulfate-linked peptides
title_sort mass spectrometric analysis of chondroitin sulfate-linked peptides
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526814/
https://www.ncbi.nlm.nih.gov/pubmed/36213313
http://dx.doi.org/10.1007/s42485-022-00092-3
work_keys_str_mv AT ramarajanmadangopal massspectrometricanalysisofchondroitinsulfatelinkedpeptides
AT saraswatmayank massspectrometricanalysisofchondroitinsulfatelinkedpeptides
AT budhrajarohit massspectrometricanalysisofchondroitinsulfatelinkedpeptides
AT garapatikishore massspectrometricanalysisofchondroitinsulfatelinkedpeptides
AT raymondkimiyo massspectrometricanalysisofchondroitinsulfatelinkedpeptides
AT pandeyakhilesh massspectrometricanalysisofchondroitinsulfatelinkedpeptides